Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
08 June 2021 | Story Legopheng Maphile | Photo Charl Devenish
Nthabiseng Kotsokoane in front of the Sasol Library on the Bloemfontein Campus of the University of the Free State. She is wearing a pink blouse with floral patterns and leaning with her left elbow against a ledge whilst looking into the camera.
Nthabiseng Kotsokoane is a renowned library professional whose passionate efforts to advance library and information services in Africa and beyond are widely acknowledged Photo: Charl Devenish

The University of the Free State is proud to announce the appointment of Nthabiseng Kotsokoane as chairperson of the International Federation of Library Associations and Institutions (IFLA) new Regional Council and member of the IFLA Governing Board 2021 – 2023.

IFLA is the leading international body representing the interests of library and information services and their users. It is the global voice of the library and information profession.

Nthabiseng Kotsokoane is currently the Assistant Director at the University of the Free State Library Information Services. She previously worked at Monash University for 10 years as a director of the library services. Ms Kotsokoane is a renowned library professional whose passionate efforts to advance library and information services in Africa and beyond are widely acknowledged. She has vast experience in serving at various committees regionally and internationally. She served as a member of the IFLA women information Libraries Special Interest Group. She was later elected by LIASA into the IFLA IT committee. She is the current IFLA Africa section Chair 2017-2021.

 

Serving the international library community

Nthabiseng is not only active in IFLA but on the African continent as well, she is the past chair for the African Library & Information Associations & Institutions (AfLIA) academic library section Chair and a member of the AfLIA Governing Board.

As IFLA’s Regional Chair her key role will be to in increase the presence of world regions in IFLA and IFLA’s presence around the world focusing on advocacy and building capacity. She will lead efforts to provide input on IFLA advocacy work and review success in developing the regional dimension of the IFLA Strategy, as well as work to promote IFLA membership and fundraising in the regions.

This will include coordination and development of Regional Division action plans, review Regional Division activities in the following regions Regional Council and Regional Divisions for Asia and Oceania, Europe, Latin America and the Caribbean, Middle East and North Africa, North America and Sub-Saharan Africa. With her passion of developing and mentoring new library professionals we are certain that this new role will be of benefit to the international library community.

News Archive

National Department of Health invests R53.5 million in UFS laboratory
2016-02-04

Description: Dr Derek Litthauer Tags: Dr Derek Litthauer

Dr Derek Litthauer
Photo: Supplied

This year has started off on a high note for Dr Derek Litthauer and his team at the South African National Control Laboratory (NCL) for Biological Products. The National Department of Health has awarded the NCL a contract to the value of R53.5 million to continue testing vaccines for the next three years.

Vaccines are biological medicines used to ensure healthy populations by preventing many diseases. The World Health Organization (WHO) estimates that, worldwide, about 5.2 million children under six years old die annually. Of these deaths, 29% are vaccine preventable. Research has revealed that vaccines prevent about 6 million deaths each year globally. Safe and effective vaccines are essential public health tools, which are strictly regulated internationally. It is the NCL’s responsibility to perform quality control testing on all vaccines to be used on humans in South Africa.

This laboratory, the only one of its kind in Africa, receives samples of vaccines from manufacturers and importers for rigorous evaluation and testing. No vaccine may be used in South Africa without a release certificate issued by the Control Lab, certifying that the vaccine is suitable for human use.

The contract is a commitment to ensuring that only vaccines of the highest quality are used in South Africa.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept